company

RETINITIS PIGMENTOSA FORENINGEN I NORGE

Return on Equity
12,34 %
Current Ratio
274,5
Debt-to-Equity Ratio
0
Key figures (NOK)2021
Revenue1 754 000
Net Income540 000
Total Assets4 392 000
Total Equity4 376 000
Income (NOK)2021
Revenue1 754 000
Expenditure−509 000
Operating Profit531 000
Financial Income9 000
Financial Costs0
Financial Balance9 000
Earnings Before Tax540 000
Tax0
Net Income540 000
Balance (NOK)2021
Total Fixed Assets0
Total Current Assets4 392 000
Total Assets4 392 000
Total Retained Equity4 376 000
Total Equity4 376 000
Total Long-Term Debt0
Total Current Debt16 000
Total Equity and Debt4 392 000
Cash flow (NOK)2021
Sales Income195 000
Other Income1 559 000
Revenue1 754 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure−509 000
Operating Profit531 000
Financial Income9 000
Financial Costs0
Financial Balance9 000
Dividends0
Net Income540 000
Balance details (NOK)2021
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank4 301 000
Total Current Assets4 392 000
Total Assets4 392 000
Total Equity4 376 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors14 000
Unpaid Taxes0
Dividends0
Other Current Debt2 000
Total Current Debt16 000
Total Equity and Debt4 392 000
Financial indicators2021
Return on Equity12,34 %
Debt-to-Equity Ratio0
Operating Profit Margin30,27 %
Current Ratio274,5
Quick Ratio274,5
Equity Ratio1
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English